Nasdaq:HARPUS41358P1066 Archives - San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events

Harpoon Therapeutics Appoints Two New Members to Its Board of Directors

April 2, 2020 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., April 01, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that it has appointed Andrew R. Robbins and… […]

Harpoon Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update

March 13, 2020 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., March 12, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today reported financial results for the fourth quarter and… […]

Harpoon Therapeutics to Participate in the Piper Jaffray Healthcare Conference

November 26, 2019 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Ch… […]

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences

November 13, 2019 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Ch… […]

Harpoon Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 7, 2019 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today reported financial results for the third quarter and n… […]

Harpoon Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 7, 2019 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today reported financial results for the third quarter and n… […]

Harpoon Therapeutics Announces Presentation on HPN328 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 23, 2019 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that an abstract regarding HPN328 for the tr… […]

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences

July 31, 2019 San Francisco Biotechnology Network News Comments Off

SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Ch… […]